Lamotrigine Tablet, Extended Release
Product Images NDC 62332-417

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 62332-417). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets Bottle Label (Lamotrigine 200mg)

FDA Label Image

30 Tablets Bottle Label (Lamotrigine 250mg)

FDA Label Image

30 Tablets Bottle Label (Lamotrigine 300mg)

FDA Label Image

Lamotrigine Description (Lamotrigine Description 1)

This is a description of pharmaceutical capsules available in various strengths and colors. The capsules are imprinted with codes "A196", "A197", and "A198". The strengths mentioned are 200 mg in blue color, 250 mg in purple, and 300 mg in grey. The text indicates the presence of the mentioned imprints on capsules of respective strengths and colors.*

FDA Label Image

Figure 1 (Lamotrigine Figure1)

This text is not readable.*

FDA Label Image

Figure 2 (Lamotrigine Figure2)

This is a statistical table comparing responder rates for improvement and worsening between a placebo group (N=120) and a group taking Lamotrigine Extended-Release Tablets (N<116). The table shows percentages of patients showing improvement or worsening in the study.*

FDA Label Image

Structure (Lamotrigine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.